NCT05153174View on ClinicalTrials.gov

Study of Sulphoraphane in Chronic Kidney Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 2, 2022

Primary Completion Date

May 25, 2023

Study Completion Date

June 8, 2023

Conditions
Chronic Kidney Disease stage3Chronic Kidney Disease stage4
Interventions
DRUG

Sulforaphane

This is an over-the counter nutritional supplement. Participants will be given the extra strength tablets.

Trial Locations (1)

14642

University of Rochester Medical Center, Rochester

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Rochester

OTHER